These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8200368)
1. The influence of tamoxifen on plasma coagulation and serous fibrinolysis. Jankowski J; Ramlau C; Kopczynski Z; Boryska M Eur J Gynaecol Oncol; 1993; 14 Suppl():155-8. PubMed ID: 8200368 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis. Oberhoff C; Szymeczek J; Hoffmann O; Winkler UH; Kaiser S; Schindler AE Breast Cancer Res Treat; 1998 Jul; 50(1):73-81. PubMed ID: 9802622 [TBL] [Abstract][Full Text] [Related]
3. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Zegura B; Guzic-Salobir B; Sebestjen M; Keber I Menopause; 2006; 13(4):643-50. PubMed ID: 16837886 [TBL] [Abstract][Full Text] [Related]
4. Effect of tamoxifen on measurements of hemostasis in healthy women. Mannucci PM; Bettega D; Chantarangkul V; Tripodi A; Sacchini V; Veronesi U Arch Intern Med; 1996 Sep; 156(16):1806-10. PubMed ID: 8790074 [TBL] [Abstract][Full Text] [Related]
5. Effects of chemoendocrine therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer. Japan Advanced Breast Cancer Study Group and Japan Clinical Oncology Group. ; Jpn J Cancer Res; 1993 Apr; 84(4):455-61. PubMed ID: 8514613 [TBL] [Abstract][Full Text] [Related]
6. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295 [TBL] [Abstract][Full Text] [Related]
7. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells. Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873 [TBL] [Abstract][Full Text] [Related]
8. Effects of combined tamoxifen and medroxyprogesterone treatment on coagulation-fibrinolytic systems in patients with advanced breast cancer. Fukutomi T; Adachi I; Watanabe T; Nanasawa T; Yamamoto H Acta Oncol; 1993; 32(5):573-4. PubMed ID: 8217244 [No Abstract] [Full Text] [Related]
9. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients. Jespersen J Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796 [TBL] [Abstract][Full Text] [Related]
12. The effect of 17 beta-oestradiol on variables of coagulation and fibrinolysis in postmenopausal women with type 2 diabetes mellitus. Brussaard HE; Leuven JA; Krans HM; Kluft C Vascul Pharmacol; 2002 Aug; 39(3):141-7. PubMed ID: 12616982 [TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women. Salobir BG; Keber I; Vrabic L Fertil Steril; 2002 Dec; 78(6):1178-83. PubMed ID: 12477508 [TBL] [Abstract][Full Text] [Related]
14. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Voss R; Matthias FR; Borkowski G; Reitz D Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855 [TBL] [Abstract][Full Text] [Related]
15. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII. Gjonnaess H; Fagerhol MK Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827 [TBL] [Abstract][Full Text] [Related]
16. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia. Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355 [TBL] [Abstract][Full Text] [Related]
18. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related]
19. [Effects on the coagulation-fibrinolysis system of a single oral dose of mesoglycan at the beginning and at the end of a prolonged treatment in man]. Blardi P; Messa G; Puccetti L; La Placa G; Ghezzi A Recenti Prog Med; 1995; 86(7-8):282-9. PubMed ID: 7569284 [TBL] [Abstract][Full Text] [Related]
20. A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy. Rella C; Coviello M; Giotta F; Maiello E; Colavito P; Colangelo D; Quaranta M; Colucci G; Schittulli F Breast Cancer Res Treat; 1996; 40(2):151-9. PubMed ID: 8879681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]